Portal de Periódicos da CAPES

Neutrophil gelatinase–associated lipocalin (NGAL) as a Biomarker for Early Acute Kidney Injury

2011; Elsevier BV; Volume: 27; Issue: 2 Linguagem: Inglês

10.1016/j.ccc.2010.12.003

1557-8232

Douglas Shemin, Lance D. Dworkin,

Sepsis Diagnosis and Treatment

Based on information to date, although limitations in the accuracy of NGAL in predicting AKI persist, the preponderance of published studies demonstrate that NGAL, when measured in the plasma and in the urine, is a reliable biomarker for the subsequent development of clinically apparent AKI. If very early detection of AKI, via the measurement of plasma or urinary NGAL, can be followed by effective treatment to abort the development or limit the severity of AKI, and therefore decrease the rate of RRT, length of hospitalization stay, and/or mortality risk, NGAL measurement will become a critically important diagnostic tool in critical care medicine, pediatrics, and surgery.